Karyo's BRCA testing is CE-IVD

  • Apr 13, 2015

Karyo is glad to announce that our NGS based BRCA testing is CE-IVD marked and has been validated as a diagnostic test for hereditary breast and ovarian cancer by Sophia Genetics, Switzerland.


Sophia DDM (Data-Driven Medicine) platform is provided by Sophia Genetics and is currently the only company in the field with both ISO 13485 (Medical Devices) and ISO27001 (Information Security).